Tandem Diabetes Care (NSDQ:TNDM) beat estimates on Wall Street today with its fourth-quarter and full-year financial results.
The company also announced today that its CEO, Kim Blickenstaff, plans to assume the role of executive chairman and that COO John Sheridan will become president and CEO on March 1.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem shuffles C-suite, beats The Street with Q4 results appeared first on MassDevice.
from MassDevice https://ift.tt/2tDzO3k
Cap comentari:
Publica un comentari a l'entrada